Form 4: GoodRx CFO Christopher McGinnis Reports Acquisition of Restricted Stock Units and Stock Options

Christopher McGinnis, CFO of GoodRx Holdings, reports the acquisition of restricted stock units and stock options in Class A Common Stock.

Summary

• Christopher McGinnis, the Chief Financial Officer & Treasurer of GoodRx Holdings, Inc., filed a Form 4 on March 5, 2025, reporting transactions that occurred on March 3, 2025.
• McGinnis acquired 716,479 restricted stock units (RSUs) and 1,096,937 stock options, both relating to Class A Common Stock.
• The RSUs vest as to 25% on February 15, 2026, with the remaining 75% vesting in equal quarterly installments over the following 12 quarters.
• Similarly, the stock options vest as to 25% on February 15, 2026, with the remaining 75% vesting in equal quarterly installments over the following 12 quarters.
• The stock options have an exercise price of $4.85 and expire on March 3, 2035.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing executive compensation. The acquisition of stock options and RSUs could be interpreted as a positive sign of the CFO's confidence in the company, but it's primarily an informational document.

Positives

• The acquisition of RSUs and stock options by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule of the RSUs and stock options suggests a multi-year incentive plan for the CFO.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in the pharmaceutical and healthcare technology industries where stock options and RSUs are used to incentivize management.

Comparison to Industry Standards

• Stock option and RSU grants are a common form of executive compensation in the tech and healthcare industries.
• Companies like Teladoc, CVS Health, and UnitedHealth Group also utilize similar equity-based compensation plans for their executives.
• The vesting schedules and exercise prices are generally aligned with industry standards to incentivize long-term performance.

Stakeholder Impact

• The granting of RSUs and stock options can align the CFO's interests with those of the shareholders, incentivizing him to increase shareholder value.

Key Dates